Document resource
Canada has become only the second country in the world to approve a generic form of the blockbuster drug Ozempic (semaglutide), made possible after its manufacturer, Novo Nordisk, did not pay a $C250 annual fee.
Annotated abstract
Ozempic generic approved in Canada after Novo Nordisk doesn't pay $250 government fee
bmj · 2026-05-19 · canonical JSON source